Is that Why vTv Therapeutics (Nasdaq: VTVT) Inc shares drowned in the late hours last night?
vTv Therapeutics (Nasdaq: VTVT) shares thwarted in the after-market hours to -37.71% to $1.85 after the company revealed that it had signed a worldwide license agreement with Anteris Bio for the world’s first clinical-stage Nrf2 activator compound, HPP971. The biotech investment firm Aditum Bio, co-founded in 2019 by former Novartis executives Joe Jimenez and Dr. […]
Psychedelic Stocks: Consider Investing In These 3 Stocks
Back in 2014 when investors started trading marijuana stocks Wall Street dubbed it as just the flavour of the year. But since then, psychedelic stocks have seen billions of dollars be invested in them and hundreds of companies revolving them have launched themselves. This is also due to the scientific research which now supports the […]